Athenex, Inc. (33)

Browse by Contract Category

Contracts

Assignment and Assumption dated as of August 4, 2020, by and among Athenex, Inc, as the borrower, Sagard Healthcare Royalty Partners, LP, OPB SHRP Co-Invest Credit Limited and... (Filed With SEC on November 5, 2020)
Intercreditor Agreement dated as of August 4, 2020, by and among Oaktree Fund Administration, LLC, as administrative agent, and Sagard Healthcare Royalty Partners, LP, and as... (Filed With SEC on November 5, 2020)
Second Supplemental Agreement to License Agreement dated December 12, 2019 by and among Athenex, Inc. and Chongqing Taihao Pharmaceutical Co. Ltd. and Guangzhou Xiangxue... (Filed With SEC on August 6, 2020)
Amended and Restated 2017 Omnibus Incentive Plan (Filed With SEC on August 6, 2020)
Description of Securities (Filed With SEC on March 2, 2020)
Security Agreement dated as of August 4, 2020, by and between Athenex, Inc. and Sagard Healthcare Royalty Partners, LP (Filed With SEC on November 5, 2020)
Underwriting Agreement, dated September 9, 2020, by and between the Company and SVB Leerink LLC, RBC Capital Markets, LLC and Evercore Group L.L.C., as representatives of the... (Filed With SEC on September 10, 2020)
Revenue Interest Financing Agreement (Filed With SEC on August 6, 2020)
Form of Warrant to Purchase Common Stock (Filed With SEC on August 6, 2020)
Registration Rights Agreement by and among Athenex, Inc. and the purchasers named therein, dated as of June 19, 2020 (Filed With SEC on August 6, 2020)
Security Agreement dated as of June 19, 2020, by and among Athenex, Inc., the subsidiary guarantors from time to time party thereto, the lenders from time to time party thereto,... (Filed With SEC on August 6, 2020)
Credit Agreement and Guaranty dated as of June 19, 2020, by and among Athenex, Inc., the subsidiary guarantors from time to time party thereto, the lenders from time to time party... (Filed With SEC on June 22, 2020)
Form of Warrant to Purchase Common Stock (Filed With SEC on June 22, 2020)
Second Amendment to License Agreement by and between Athenex, Inc. and PharmaEssentia Corp., effective as of November 27, 2018 (Filed With SEC on May 7, 2020)
License Agreement by and between Kinex Pharmaceuticals, LLC and Guangzhou Xiangxue New Drug Discovery and Development Company Limited, effective as of May 6, 2012 (Filed With SEC on May 7, 2020)
License Agreement by and between Kinex Pharmaceuticals, Inc. and PharmaEssentia Corp., effective as of December 16, 2013 (Filed With SEC on May 7, 2020)
License Agreement between the Company and Guangzhou Xiangxue Pharmaceutical Co., Ltd. dated December 12, 2019 (Filed With SEC on December 16, 2019)
Form of Registration Rights Agreement (Filed With SEC on December 5, 2019)
Share Purchase Agreement, by and among Athenex, Inc., M. Kingdon Offshore Master Fund, LP, Schonfeld Strategic 460 Fund LLC, Point72 Associates, LLC, J. Goldman Master Fund, L.P.,... (Filed With SEC on December 5, 2019)
Amendment to Grant Disbursement Agreement by and between the New York State Urban Development Corporation d/b/a Empire State Development and Athenex, Inc (Filed With SEC on August 7, 2019)
Amendment No. 2 to Credit Agreement by and between Athenex, Inc. and Perceptive Advisors LLC, dated as of August 5, 2019 (Filed With SEC on August 7, 2019)
Amendment No. 1 to Credit Agreement by and between Athenex, Inc. and Perceptive Advisors LLC, dated as of April 22, 2019 (Filed With SEC on August 7, 2019)
Second Amendment to License and Development Agreement by and between Athenex, Inc., Almirall, S.A., and Aqua Pharmaceuticals LLC, dated as of June 18, 2019 (Filed With SEC on August 7, 2019)
Supplemental Agreement to Athenex Pharmaceutical Base Project Located in the Chongqing Maliu Riverside Development Zone Agreement with Chongqing Maliu Riverside Development and... (Filed With SEC on August 7, 2019)
Second Amendment to Agreement by and between M+W U.S., Inc. and Athenex, Inc., effective as of October 1, 2018 (Filed With SEC on May 9, 2019)
First Amendment to Agreement by and between M+W U.S., Inc. and Athenex, Inc., effective as of March 27, 2018 (Filed With SEC on May 9, 2019)
Form of Registration Rights Agreement (Filed With SEC on May 6, 2019)
Share Purchase Agreement, by and among Athenex, Inc., Perceptive Life Sciences Master Fund, Ltd., venBio Select Fund LLC, OrbiMed Partners Master Fund Limited, and The Biotech... (Filed With SEC on May 6, 2019)
Second Amendment to License Agreement by and between Athenex, Inc. and PharmaEssentia Corp., effective as of November 27, 2018 (Filed With SEC on March 11, 2019)
Fifth Amendment to License Agreement by and between Athenex, Inc. and Hanmi Pharmaceutical Co. Ltd., effective as of September 4, 2018 (Filed With SEC on March 11, 2019)
Mutual Letter of Termination of the License Agreement by and between Kinex Pharmaceuticals, LLC and Hanmi Pharmaceutical Ltd., effective as of August 20, 2018 (Filed With SEC on March 11, 2019)
License Agreement, dated as of December 30, 2018 by and between Athenex, Inc. and Chongqing Taihao Pharmaceutical Co. Ltd (Filed With SEC on January 3, 2019)
Sublicense Agreement, dated as of December 30, 2018 by and among Chongqing Taihao Pharmaceutical Co. Ltd., Chongqing Jingdong Junzhuo Pharmaceutical Co., Ltd., and Athenex, Inc (Filed With SEC on January 3, 2019)